Category: Infectious Diseases

Infectious Diseases

FDA-Cleared Molecular Test Targets Growing US Cyclospora Outbreak

QIAGEN’s FDA-cleared QIAstat-Dx panel detects Cyclospora cayetanensis, addressing a surge of over 1,600 confirmed US cases since May 2026.

Infectious Diseases

FDA Clears Rapid Molecular Test for Group A Strep

The point-of-care assay provides results in 15 minutes and received a waiver for use in decentralized settings.

Infectious Diseases

ARUP Laboratories Launches Infectious Disease Trend Dashboard

ARUP Laboratories has launched a dashboard tracking national infectious disease test positivity trends, using deidentified lab data to help clinical labs and medical directors identify emerging patterns and seasonal shifts.

Emerging & Zoonotic Diseases

Molecular Platform Shows Promise for Detecting Asymptomatic Malaria Cases

A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.

Flu & Respiratory Infections

CE Mark Granted for Rapid Bacterial vs Viral Infection Test

The high-throughput host-response assay provides results in approximately 20 minutes to help guide treatment decisions and antimicrobial stewardship.

Gastrointestinal Infections

FDA Clears Cepheid’s Multiplex GI Pathogen Panel

The PCR test detects 11 bacterial, viral, and parasitic pathogens from a stool sample in approximately 74 minutes.

Sexually Transmitted Diseases

Blood Test May Improve Risk Assessment for HPV-Related Throat Cancer

Research identifies how circulating tumor DNA can inform personalized treatment and surveillance strategies.